Travis J. Haller
Papers
1
Total Citations
16
H-Index
1
About
Travis J. Haller is a leading surgical oncologist whose research focuses on the optimization of treatment for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. His major contributions center on de-escalation strategies, aiming to reduce treatment morbidity without compromising oncologic outcomes. In his pivotal 2023 study, Haller analyzed 30-day morbidity and mortality following transoral robotic surgery (TORS) within two prospective adjuvant de-escalation trials (MC1273 and MC1675), demonstrating that minimally invasive surgical approaches can be safely integrated into reduced-intensity treatment protocols. This work, which has garnered 16 citations, provides critical evidence for refining post-surgical adjuvant therapy, helping to spare patients from the long-term toxicities of high-dose chemoradiation. Haller’s research is instrumental in advancing personalized, function-preserving care for HPV-positive head and neck cancer patients, establishing benchmarks for safety and efficacy in modern surgical oncology. His findings continue to shape clinical guidelines and inspire further investigation into de-escalation paradigms.
Research Focus
Key Achievements
Top Papers
- 1